CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (CTMX)

CUSIP: 23284F105

Q4 2018 13F Holders as of 31 Dec 2018

Security identity
Security type / class
Equity / Common Stock, $0.00001 par value per share ("Common Stock")
Shares outstanding
217,079,600
Holder snapshot
Total 13F shares
37,768,617
Share change
+100,502
Total reported value
$569,884,178
Put/Call ratio
0%
Reported price per share
$15.10
Number of holders
108
Value change
-$2,745,916
Number of buys
49
Number of sells
60

Security key

23284F105

Report period

Q4 2018

Institutions

108

Top holders

10

CTMX full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2019 Previous quarter: Q3 2018 CytomX Therapeutics, Inc. SEC filings CytomX Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CTMX - CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share ("Common Stock") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
FMR LLC
13D/G signal
—
Evidence rows
15
Latest as of
30 Sep 2018
13F Lead comparable stake: 3.1% Showing 1-6 of 15 holder rows.

Rank 1 holder

FMR LLC

13F
Ownership
3.1%
Position
$124.77M
13F
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
3.1%
$124,774,000
6,744,553 shares
 — 30 Sep 2018
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
1.9%
$75,621,000
4,087,603 shares
 — 30 Sep 2018
BlackRock Finance, Inc.
13F
Company
13F
1.8%
$71,570,000
3,868,566 shares
 — 30 Sep 2018
PERCEPTIVE ADVISORS LLC
13F
Company
13F
1.2%
$49,242,000
2,661,715 shares
 — 30 Sep 2018
VANGUARD GROUP INC
13F
Company
13F
1.2%
$46,343,000
2,504,987 shares
 — 30 Sep 2018
STATE STREET CORP
13F
Company
13F
0.91%
$36,658,000
1,981,550 shares
 — 30 Sep 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
108
Shares
37,768,617
Rows available
108
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders
119
Q4 2018 holders
108
Holder diff
-11
Investor Q3 2018 Shares Q4 2018 Shares Share Diff Share Chg % Q3 2018 value Q4 2018 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .